{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:51:46Z","timestamp":1792691506343,"version":"4.5.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12035-025-05189-6","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:58:20Z","timestamp":1751954300000},"page":"15349-15364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exosome-Mediated Delivery of Amyloid Beta Modulators: A Potential Therapeutic Strategy for Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Tehreem","family":"Mushtaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8636-8644","authenticated-orcid":false,"given":"Huma","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2710-6000","authenticated-orcid":false,"given":"Ana","family":"Cl\u00e1udia\u00a0Paiva-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urwa","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-3383","authenticated-orcid":false,"given":"Anam","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"5189_CR1","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114183","volume":"358","author":"P Gomes","year":"2022","unstructured":"Gomes P et al (2022) Extracellular vesicles and Alzheimer\u2019s disease in the novel era of precision medicine: implications for disease progression, diagnosis and treatment. Exp Neurol 358:114183","journal-title":"Exp Neurol"},{"issue":"3","key":"5189_CR2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.trci.2017.07.001","volume":"3","author":"KL Lanct\u00f4t","year":"2017","unstructured":"Lanct\u00f4t KL et al (2017) Neuropsychiatric signs and symptoms of Alzheimer\u2019s disease: new treatment paradigms. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions 3(3):440\u2013449","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"issue":"4","key":"5189_CR3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","volume":"19","author":"MA Better","year":"2023","unstructured":"Better MA (2023) Alzheimer\u2019s disease facts and figures. Alzheimers Dement 19(4):1598\u20131695","journal-title":"Alzheimers Dement"},{"issue":"1","key":"5189_CR4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JAD-180688","volume":"66","author":"AJ Ehrenberg","year":"2018","unstructured":"Ehrenberg AJ et al (2018) Neuropathologic correlates of psychiatric symptoms in Alzheimer\u2019s disease. J Alzheimers Dis 66(1):115\u2013126","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"5189_CR5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13041-024-01118-1","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A (2024) The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease states. Mol Brain 17(1):44","journal-title":"Mol Brain"},{"key":"5189_CR6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW et al (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions 4:575\u2013590","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"issue":"2","key":"5189_CR7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jnc.15112","volume":"156","author":"T Soares Martins","year":"2021","unstructured":"Soares Martins T et al (2021) Diagnostic and therapeutic potential of exosomes in Alzheimer\u2019s disease. J Neurochem 156(2):162\u2013181","journal-title":"J Neurochem"},{"issue":"1","key":"5189_CR8","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10367","volume":"8","author":"P Chopade","year":"2023","unstructured":"Chopade P et al (2023) Alzheimer\u2019s and Parkinson\u2019s disease therapies in the clinic. Bioengineering & Translational Medicine 8(1):e10367","journal-title":"Bioengineering & Translational Medicine"},{"key":"5189_CR9","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.2147\/JIR.S466821","volume":"17","author":"M Sun","year":"2024","unstructured":"Sun M, Chen Z (2024) Unveiling the complex role of exosomes in Alzheimer\u2019s disease. J Inflamm Res 17:3921\u20133948","journal-title":"J Inflamm Res"},{"key":"5189_CR10","doi-asserted-by":"crossref","unstructured":"Kalluri R and LeBleu  VS (2020)\u00a0The biology, function, and biomedical applications of exosomes. Science\u00a0367(6478):eaau6977","DOI":"10.1126\/science.aau6977"},{"issue":"10","key":"5189_CR11","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/1873-3468.14074","volume":"595","author":"LR Lizarraga-Valderrama","year":"2021","unstructured":"Lizarraga-Valderrama LR, Sheridan GK (2021) Extracellular vesicles and intercellular communication in the central nervous system. FEBS Lett 595(10):1391\u20131410","journal-title":"FEBS Lett"},{"key":"5189_CR12","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101321","volume":"68","author":"T Zhang","year":"2021","unstructured":"Zhang T et al (2021) The emerging role of exosomes in Alzheimer\u2019s disease. Ageing Res Rev 68:101321","journal-title":"Ageing Res Rev"},{"key":"5189_CR13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnmol.2020.00038","volume":"13","author":"S Hornung","year":"2020","unstructured":"Hornung S, Dutta S, Bitan G (2020) CNS-derived blood exosomes as a promising source of biomarkers: opportunities and challenges. Front Mol Neurosci 13:38","journal-title":"Front Mol Neurosci"},{"issue":"19","key":"5189_CR14","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.3390\/ijms221910794","volume":"22","author":"HM Soliman","year":"2021","unstructured":"Soliman HM et al (2021) Exosomes in Alzheimer\u2019s disease: from being pathological players to potential diagnostics and therapeutics. Int J Mol Sci 22(19):10794","journal-title":"Int J Mol Sci"},{"key":"5189_CR15","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2023.108365","volume":"118","author":"S Upadhyaya","year":"2023","unstructured":"Upadhyaya S et al (2023) Maternal SSRI use during pregnancy and offspring depression or anxiety disorders: a review of the literature and description of a study protocol for a register-based cohort study. Reprod Toxicol 118:108365","journal-title":"Reprod Toxicol"},{"key":"5189_CR16","volume":"14","author":"S Weng","year":"2022","unstructured":"Weng S et al (2022) The role of exosomes as mediators of neuroinflammation in the pathogenesis and treatment of Alzheimer\u2019s disease. Frontiers in Aging Neuroscience 14:899944x","journal-title":"Frontiers in Aging Neuroscience"},{"key":"5189_CR17","volume":"13","author":"P Gao","year":"2021","unstructured":"Gao P et al (2021) Diagnostic and therapeutic potential of exosomes in neurodegenerative diseases. Frontiers in Aging Neuroscience 13:790863","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"9","key":"5189_CR18","doi-asserted-by":"crossref","first-page":"12922","DOI":"10.1096\/fj.202000823R","volume":"34","author":"R P\u00e9rez-Gonz\u00e1lez","year":"2020","unstructured":"P\u00e9rez-Gonz\u00e1lez R et al (2020) Extracellular vesicles: where the amyloid precursor protein carboxyl-terminal fragments accumulate and amyloid-\u03b2 oligomerizes. FASEB J 34(9):12922","journal-title":"FASEB J"},{"issue":"12","key":"5189_CR19","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/s41374-021-00644-z","volume":"101","author":"E Miyoshi","year":"2021","unstructured":"Miyoshi E et al (2021) Exosomal tau with seeding activity is released from Alzheimer\u2019s disease synapses, and seeding potential is associated with amyloid beta. Lab Invest 101(12):1605\u20131617","journal-title":"Lab Invest"},{"key":"5189_CR20","unstructured":"Elsherbini A (2020)\u00a0Ceramide-enriched extracellular vesicles: a role in enhancing amyloid-beta neurotoxicity and mitochondrial damage in alzheimer\u2019s disease"},{"key":"5189_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fnagi.2020.00265","volume":"12","author":"P d'Errico","year":"2020","unstructured":"d\u2019Errico P, Meyer-Luehmann M (2020) Mechanisms of pathogenic tau and A\u03b2 protein spreading in Alzheimer\u2019s disease. Front Aging Neurosci 12:265","journal-title":"Front Aging Neurosci"},{"key":"5189_CR22","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.742408","volume":"14","author":"MB Abubakar","year":"2022","unstructured":"Abubakar MB et al (2022) Alzheimer\u2019s disease: an update and insights into pathophysiology. Frontiers in aging neuroscience 14:742408","journal-title":"Frontiers in aging neuroscience"},{"key":"5189_CR23","unstructured":"Zheng Q and Wang  X (2024) Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein & Cell pwae026"},{"issue":"3","key":"5189_CR24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4103\/1673-5374.320970","volume":"17","author":"Y Ju","year":"2022","unstructured":"Ju Y, Tam KY (2022) Pathological mechanisms and therapeutic strategies for Alzheimer\u2019s disease. Neural Regen Res 17(3):543\u2013549","journal-title":"Neural Regen Res"},{"issue":"12","key":"5189_CR25","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/biomedicines9121910","volume":"9","author":"V Garc\u00eda-Morales","year":"2021","unstructured":"Garc\u00eda-Morales V et al (2021) Current understanding of the physiopathology, diagnosis and therapeutic approach to Alzheimer\u2019s disease. Biomedicines 9(12):1910","journal-title":"Biomedicines"},{"issue":"3","key":"5189_CR26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/biology11030413","volume":"11","author":"M Kumari","year":"2022","unstructured":"Kumari M, Anji A (2022) Small but mighty\u2014exosomes, novel intercellular messengers in neurodegeneration. Biology 11(3):413","journal-title":"Biology"},{"key":"5189_CR27","doi-asserted-by":"crossref","unstructured":"Graykowski DR et al (2020) The dichotomous role of extracellular vesicles in the central nervous system. Iscience\u00a023(9)","DOI":"10.1016\/j.isci.2020.101456"},{"key":"5189_CR28","volume":"10","author":"L Ding","year":"2022","unstructured":"Ding L et al (2022) Exosomes mediate APP dysregulation via APP-miR-185-5p Axis. Frontiers in Cell and Developmental Biology 10:793388","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"5","key":"5189_CR29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10719-022-10066-8","volume":"39","author":"K Yuyama","year":"2022","unstructured":"Yuyama K, Igarashi Y (2022) Linking glycosphingolipids to Alzheimer\u2019s amyloid-\u00df: extracellular vesicles and functional plant materials. Glycoconj J 39(5):613\u2013618","journal-title":"Glycoconj J"},{"key":"5189_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00420-5","volume":"16","author":"BS Ulm","year":"2021","unstructured":"Ulm BS, Borchelt DR, Moore BD (2021) Remodeling Alzheimer-amyloidosis models by seeding. Mol Neurodegener 16:1\u201311","journal-title":"Mol Neurodegener"},{"issue":"22","key":"5189_CR31","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1111\/febs.16055","volume":"289","author":"JC Polanco","year":"2022","unstructured":"Polanco JC, G\u00f6tz J (2022) Exosomal and vesicle-free tau seeds\u2014propagation and convergence in endolysosomal permeabilization. FEBS J 289(22):6891\u20136907","journal-title":"FEBS J"},{"key":"5189_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-016-0142-z","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang Y et al (2017) The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener 12:1\u201325","journal-title":"Mol Neurodegener"},{"issue":"1","key":"5189_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40478-020-00931-8","volume":"8","author":"A Elsherbini","year":"2020","unstructured":"Elsherbini A, Kirov AS, Dinkins MB, Wang G, Qin H, Zhu Z, Tripathi P, Crivelli SM, Bieberich E (2020) Association of A\u03b2 with ceramide-enriched astrosomes mediates A\u03b2 neurotoxicity. Acta Neuropathol Commun 8(1):60. https:\/\/doi.org\/10.1186\/s40478-020-00931-8","journal-title":"Acta Neuropathol Commun"},{"key":"5189_CR34","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10571-020-00905-3","volume":"41","author":"F Fricke","year":"2021","unstructured":"Fricke F et al (2021) Proinflammatory extracellular vesicle-mediated signaling contributes to the induction of neuroinflammation in animal models of endotoxemia and peripheral surgical stress. Cell Mol Neurobiol 41:1325\u20131336","journal-title":"Cell Mol Neurobiol"},{"key":"5189_CR35","doi-asserted-by":"crossref","unstructured":"Tamagno E et al (2021) Oxidative stress and beta amyloid in Alzheimer\u2019s disease. Which comes first: the chicken or the egg? Antioxidants 10(9):1479","DOI":"10.3390\/antiox10091479"},{"key":"5189_CR36","volume":"65","author":"A John","year":"2021","unstructured":"John A, Reddy PH (2021) Synaptic basis of Alzheimer\u2019s disease: focus on synaptic amyloid beta. P-tau and mitochondria Ageing research reviews 65:101208","journal-title":"P-tau and mitochondria Ageing research reviews"},{"issue":"6","key":"5189_CR37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jnc.15007","volume":"154","author":"S Li","year":"2020","unstructured":"Li S, Selkoe DJ (2020) A mechanistic hypothesis for the impairment of synaptic plasticity by soluble A\u03b2 oligomers from Alzheimer\u2019s brain. J Neurochem 154(6):583\u2013597","journal-title":"J Neurochem"},{"issue":"2","key":"5189_CR38","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","volume":"19","author":"A Gustavsson","year":"2023","unstructured":"Gustavsson A et al (2023) Global estimates on the number of persons across the Alzheimer\u2019s disease continuum. Alzheimers Dement 19(2):658\u2013670","journal-title":"Alzheimers Dement"},{"issue":"5","key":"5189_CR39","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.gendis.2022.03.021","volume":"10","author":"M Xu","year":"2023","unstructured":"Xu M et al (2023) The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): intercellular shuttles and implications in human diseases. Genes & Diseases 10(5):1894\u20131907","journal-title":"Genes & Diseases"},{"issue":"7","key":"5189_CR40","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/cells8070727","volume":"8","author":"LM Doyle","year":"2019","unstructured":"Doyle LM, Wang MZ (2019) Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 8(7):727","journal-title":"Cells"},{"key":"5189_CR41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fnmol.2020.00079","volume":"13","author":"Z Song","year":"2020","unstructured":"Song Z et al (2020) Brain derived exosomes are a double-edged sword in Alzheimer\u2019s disease. Front Mol Neurosci 13:79","journal-title":"Front Mol Neurosci"},{"key":"5189_CR42","doi-asserted-by":"crossref","unstructured":"Johansson L et al (2024) Lack of cellular prion protein causes amyloid \u03b2 accumulation, increased extracellular vesicle abundance, and changes to exosome biogenesis proteins.\u00a0Mol Cell Biochem 1\u201314","DOI":"10.1007\/s11010-024-05059-0"},{"issue":"10","key":"5189_CR43","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3390\/pharmaceutics14102252","volume":"14","author":"K Sun","year":"2022","unstructured":"Sun K et al (2022) Exosomes as CNS drug delivery tools and their applications. Pharmaceutics 14(10):2252","journal-title":"Pharmaceutics"},{"key":"5189_CR44","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1007\/s00436-015-4659-9","volume":"114","author":"I Evans-Osses","year":"2015","unstructured":"Evans-Osses I, Reichembach LH, Ramirez MI (2015) Exosomes or microvesicles? Two kinds of extracellular vesicles with different routes to modify protozoan-host cell interaction. Parasitol Res 114:3567\u20133575","journal-title":"Parasitol Res"},{"issue":"1","key":"5189_CR45","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M et al (2015) Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 4(1):27066x","journal-title":"Journal of extracellular vesicles"},{"key":"5189_CR46","doi-asserted-by":"crossref","unstructured":"Battistelli M and Falcieri  E (2021)\u00a0Apoptotic bodies: particular extracellular vesicles involved in intercellular communication.\u00a0Adv Med Biochem Genom Physiol Pathol 473\u2013486","DOI":"10.1201\/9781003180449-20"},{"issue":"4","key":"5189_CR47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","volume":"6","author":"D Ha","year":"2016","unstructured":"Ha D, Yang N, Nadithe V (2016) Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharmaceutica Sinica B 6(4):287\u2013296","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"5189_CR48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","volume":"75","author":"NP Hessvik","year":"2018","unstructured":"Hessvik NP, Llorente A (2018) Current knowledge on exosome biogenesis and release. Cell Mol Life Sci 75:193\u2013208","journal-title":"Cell Mol Life Sci"},{"key":"5189_CR49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10354-016-0432-7","volume":"166","author":"SR Elkin","year":"2016","unstructured":"Elkin SR, Lakoduk AM, Schmid SL (2016) Endocytic pathways and endosomal trafficking: a primer. Wien Med Wochenschr 166:196\u2013204","journal-title":"Wien Med Wochenschr"},{"issue":"5","key":"5189_CR50","doi-asserted-by":"crossref","first-page":"930","DOI":"10.4103\/1673-5374.232490","volume":"13","author":"Z-Y Cai","year":"2018","unstructured":"Cai Z-Y et al (2018) Exosomes: a novel therapeutic target for Alzheimer\u2019s disease? Neural Regen Res 13(5):930\u2013935","journal-title":"Neural Regen Res"},{"issue":"2","key":"5189_CR51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.molcel.2014.11.013","volume":"57","author":"Y-M Kim","year":"2015","unstructured":"Kim Y-M et al (2015) mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation. Mol Cell 57(2):207\u2013218","journal-title":"Mol Cell"},{"issue":"4","key":"5189_CR52","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G Van Niel","year":"2018","unstructured":"Van Niel G, d\u2019Angelo G, Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19(4):213\u2013228","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5189_CR53","doi-asserted-by":"crossref","unstructured":"Janas AM et al (2016)\u00a0Exosomes and other extracellular vesicles in neural cells and neurodegenerative diseases.\u00a0Biochim Biophys Acta BBA-Biomembr\u00a01858(6):1139\u20131151","DOI":"10.1016\/j.bbamem.2016.02.011"},{"issue":"2","key":"5189_CR54","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13349","volume":"85","author":"R Kandimalla","year":"2021","unstructured":"Kandimalla R et al (2021) Milk exosomes: a biogenic nanocarrier for small molecules and macromolecules to combat cancer. Am J Reprod Immunol 85(2):e13349","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"5189_CR55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2015.10.020","volume":"371","author":"R Munagala","year":"2016","unstructured":"Munagala R et al (2016) Bovine milk-derived exosomes for drug delivery. Cancer Lett 371(1):48\u201361","journal-title":"Cancer Lett"},{"issue":"3","key":"5189_CR56","first-page":"789","volume":"7","author":"P Li","year":"2017","unstructured":"Li P et al (2017) Progress in exosome isolation techniques Theranostics 7(3):789","journal-title":"Progress in exosome isolation techniques Theranostics"},{"issue":"1","key":"5189_CR57","doi-asserted-by":"crossref","first-page":"27031","DOI":"10.3402\/jev.v4.27031","volume":"4","author":"RJ Lobb","year":"2015","unstructured":"Lobb RJ et al (2015) Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles 4(1):27031","journal-title":"Journal of extracellular vesicles"},{"key":"5189_CR58","doi-asserted-by":"crossref","unstructured":"Lobb R and M\u00f6ller A (2017) Size exclusion chromatography: a simple and reliable method for exosome purification.\u00a0Extracell Vesicles Methods Protoc 105\u2013110","DOI":"10.1007\/978-1-4939-7253-1_9"},{"key":"5189_CR59","volume":"8","author":"M Xu","year":"2020","unstructured":"Xu M et al (2020) Recent advancements in the loading and modification of therapeutic exosomes. Frontiers in Bioengineering and Biotechnology 8:586130","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"5189_CR60","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2019.02.021","volume":"493","author":"B-Y Chen","year":"2019","unstructured":"Chen B-Y et al (2019) Advances in exosomes technology. Clin Chim Acta 493:14\u201319","journal-title":"Clin Chim Acta"},{"issue":"5","key":"5189_CR61","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/nano8050310","volume":"8","author":"M-Y Hsu","year":"2018","unstructured":"Hsu M-Y et al (2018) Based microfluidic platforms for understanding the role of exosomes in the pathogenesis of major blindness-threatening diseases. Nanomaterials 8(5):310","journal-title":"Nanomaterials"},{"issue":"1","key":"5189_CR62","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C et al (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7(1):1535750","journal-title":"Journal of extracellular vesicles"},{"issue":"1","key":"5189_CR63","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41746-019-0090-4","volume":"2","author":"A Coravos","year":"2019","unstructured":"Coravos A, Khozin S, Mandl KD (2019) Developing and adopting safe and effective digital biomarkers to improve patient outcomes. NPJ digital medicine 2(1):14","journal-title":"NPJ digital medicine"},{"key":"5189_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-019-0551-7","volume":"11","author":"V van der Velpen","year":"2019","unstructured":"van der Velpen V et al (2019) Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease. Alzheimer\u2019s Research & Therapy 11:1\u201312","journal-title":"Alzheimer's Research & Therapy"},{"issue":"6","key":"5189_CR65","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow K, Zetterberg H (2018) Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future. J Intern Med 284(6):643\u2013663","journal-title":"J Intern Med"},{"key":"5189_CR66","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.118549","volume":"350","author":"S Salarpour","year":"2022","unstructured":"Salarpour S et al (2022) The application of exosomes and exosome-nanoparticle in treating brain disorders. J Mol Liq 350:118549","journal-title":"J Mol Liq"},{"key":"5189_CR67","volume":"184","author":"T-R Li","year":"2019","unstructured":"Li T-R et al (2019) Extracellular vesicles as an emerging tool for the early detection of Alzheimer\u2019s disease. Mech Ageing Dev 184:111175","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"5189_CR68","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1038\/s41598-021-90366-5","volume":"11","author":"M Bruzova","year":"2021","unstructured":"Bruzova M et al (2021) Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up. Sci Rep 11(1):10837","journal-title":"Sci Rep"},{"issue":"9","key":"5189_CR69","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/brain\/awv181","volume":"138","author":"T Skillb\u00e4ck","year":"2015","unstructured":"Skillb\u00e4ck T et al (2015) Cerebrospinal fluid tau and amyloid-\u03b21-42 in patients with dementia. Brain 138(9):2716\u20132731","journal-title":"Brain"},{"key":"5189_CR70","doi-asserted-by":"crossref","unstructured":"Cheng \u00e1 et al (2015)\u00a0Prognostic serum miRNA biomarkers associated with Alzheimer\u2019s disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry\u00a020(10):1188\u20131196","DOI":"10.1038\/mp.2014.127"},{"issue":"Suppl 1","key":"5189_CR71","first-page":"A88","volume":"89","author":"T Wu","year":"2018","unstructured":"Wu T et al (2018) I02 Systemic injection of exosomal sirna significantly reduced huntingtin expression in transgenic mice of huntington\u2019s disease. J Neurol Neurosurg Psychiatry 89(Suppl 1):A88\u2013A89","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"5189_CR72","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.4103\/1673-5374.369123","volume":"18","author":"T-Q Duan","year":"2023","unstructured":"Duan T-Q et al (2023) Adipose mesenchymal stem cell-derived extracellular vesicles reduce glutamate-induced excitotoxicity in the retina. Neural Regen Res 18(10):2315\u20132320","journal-title":"Neural Regen Res"},{"issue":"4","key":"5189_CR73","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3171\/2014.11.JNS14770","volume":"122","author":"Y Zhang","year":"2015","unstructured":"Zhang Y et al (2015) Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg 122(4):856\u2013867","journal-title":"J Neurosurg"},{"issue":"12","key":"5189_CR74","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1021\/acsptsci.4c00400","volume":"7","author":"SK Saxena","year":"2024","unstructured":"Saxena SK, Ansari S, Maurya VK, Kumar S, Sharma D, Malhotra HS, Tiwari S, Srivastava C, Paweska JT, Abdel-Moneim AS, Nityanand S (2024) Neprilysin-mediated amyloid beta clearance and its therapeutic implications in neurodegenerative disorders. ACS Pharmacol Transl Sci 7(12):3645\u20133657. https:\/\/doi.org\/10.1021\/acsptsci.4c00400","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"27","key":"5189_CR75","doi-asserted-by":"publisher","first-page":"11485","DOI":"10.1074\/jbc.M117.786558","volume":"292","author":"TJ Perlenfein","year":"2017","unstructured":"Perlenfein TJ, Mehlhoff JD, Murphy RM (2017) Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with \u03b2-amyloid. J Biol Chem 292(27):11485\u201311498. https:\/\/doi.org\/10.1074\/jbc.M117.786558","journal-title":"J Biol Chem"},{"key":"5189_CR76","unstructured":"Yelick J (2018) Neuronal exosomal miR-124 regulation of glutamate uptake. Tufts University-Graduate School of Biomedical Sciences"},{"issue":"1","key":"5189_CR77","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev-immunol-041015-055700","volume":"36","author":"MF Lindenbergh","year":"2018","unstructured":"Lindenbergh MF, Stoorvogel W (2018) Antigen presentation by extracellular vesicles from professional antigen-presenting cells. Annu Rev Immunol 36(1):435\u2013459x","journal-title":"Annu Rev Immunol"},{"key":"5189_CR78","volume":"987","author":"M Afzal","year":"2024","unstructured":"Afzal M et al (2024) Bioengineered exosomes: cellular membrane-camouflaged biomimetic nanocarriers for Parkinson\u2019s disease management. Eur J Pharmacol 987:177199","journal-title":"Eur J Pharmacol"},{"key":"5189_CR79","doi-asserted-by":"crossref","unstructured":"Jung YH et al (2025)Exosome-mediated mitochondrial regulation: a promising therapeutic tool for Alzheimer\u2019s disease and Parkinson\u2019s disease. Int J Nanomed 4903\u20134917","DOI":"10.2147\/IJN.S513816"},{"key":"5189_CR80","doi-asserted-by":"crossref","first-page":"1562565","DOI":"10.3389\/fcell.2025.1562565","volume":"13","author":"D Yang","year":"2025","unstructured":"Yang D et al (2025) Exosome-mediated dual drug delivery of curcumin and methylene blue for enhanced cognitive function and mechanistic elucidation in Alzheimer\u2019s disease therapy. Frontiers in Cell and Developmental Biology 13:1562565","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1","key":"5189_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11033-024-10097-4","volume":"52","author":"D Sharma","year":"2025","unstructured":"Sharma D, Srivastava S, Babu MR (2025) Precision exosome engineering for neurological therapeutics: molecular mechanisms and targeted strategies. Mol Biol Rep 52(1):1\u201315","journal-title":"Mol Biol Rep"},{"issue":"1","key":"5189_CR82","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1038\/s41598-023-36772-3","volume":"13","author":"EM Elzayat","year":"2023","unstructured":"Elzayat EM et al (2023) Therapeutic potential of stem cells and acitretin on inflammatory signaling pathway-associated genes regulated by miRNAs 146a and 155 in AD-like rats. Sci Rep 13(1):9613","journal-title":"Sci Rep"},{"key":"5189_CR83","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135308","volume":"738","author":"FN Cankara","year":"2020","unstructured":"Cankara FN et al (2020) The neuroprotective action of lenalidomide on rotenone model of Parkinson\u2019s disease: neurotrophic and supportive actions in the substantia nigra pars compacta. Neurosci Lett 738:135308","journal-title":"Neurosci Lett"},{"key":"5189_CR84","volume":"14","author":"X-Y Zheng","year":"2022","unstructured":"Zheng X-Y et al (2022) Levetiracetam alleviates cognitive decline in Alzheimer\u2019s disease animal model by ameliorating the dysfunction of the neuronal network. Frontiers in aging neuroscience 14:888784","journal-title":"Frontiers in aging neuroscience"},{"issue":"1","key":"5189_CR85","first-page":"7039138","volume":"2020","author":"MS Uddin","year":"2020","unstructured":"Uddin MS et al (2020) Novel anti-Alzheimer\u2019s therapeutic molecules targeting amyloid precursor protein processing. Oxid Med Cell Longev 2020(1):7039138","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"5189_CR86","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.4103\/1673-5374.313044","volume":"16","author":"X-Q Chen","year":"2021","unstructured":"Chen X-Q (2021) A pilot exploration with Posiphen to normalize amyloid precursor protein in Down syndrome. Neural Regen Res 16(12):2420\u20132421","journal-title":"Neural Regen Res"},{"issue":"8","key":"5189_CR87","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/13543784.2022.2095261","volume":"31","author":"M Lozupone","year":"2022","unstructured":"Lozupone M et al (2022) ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer\u2019s disease. Expert Opin Investig Drugs 31(8):759\u2013771","journal-title":"Expert Opin Investig Drugs"},{"key":"5189_CR88","doi-asserted-by":"crossref","unstructured":"Liu Y et al (2023) The novel function of bexarotene for neurological diseases.\u00a0Ageing Res Rev 102021","DOI":"10.1016\/j.arr.2023.102021"},{"issue":"1","key":"5189_CR89","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","volume":"12","author":"M Tolar","year":"2020","unstructured":"Tolar M et al (2020) Aducanumab, gantenerumab, BAN2401, and ALZ-801\u2014the first wave of amyloid-targeting drugs for Alzheimer\u2019s disease with potential for near term approval. Alzheimer\u2019s research & therapy 12(1):95","journal-title":"Alzheimer's research & therapy"},{"issue":"19","key":"5189_CR90","volume":"24","author":"J Kim","year":"2023","unstructured":"Kim J et al (2023) Failure, success, and future direction of alzheimer drugs targeting amyloid-\u03b2 cascade: pros and cons of chemical and biological modalities. ChemBioChem 24(19):e202300328","journal-title":"ChemBioChem"},{"issue":"s1","key":"5189_CR91","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.3233\/JAD-240140","volume":"101","author":"B Du","year":"2024","unstructured":"Du B et al (2024) Targeting metals in Alzheimer\u2019s disease: an update. J Alzheimer Dis 101(s1):S141\u2013S154","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"s1","key":"5189_CR92","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.3233\/JAD-231126","volume":"101","author":"HH Feldman","year":"2024","unstructured":"Feldman HH et al (2024) Varoglutamstat: inhibiting glutaminyl cyclase as a novel target of therapy in early Alzheimer\u2019s disease. J Alzheimer Dis 101(s1):S79\u2013S93","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"5","key":"5189_CR93","first-page":"363","volume":"329","author":"HD Larkin","year":"2023","unstructured":"Larkin HD (2023) Lecanemab gains FDA approval for early Alzheimer disease. JAMA 329(5):363\u2013363","journal-title":"JAMA"},{"issue":"1","key":"5189_CR94","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","volume":"20","author":"L S\u00f6derberg","year":"2023","unstructured":"S\u00f6derberg L et al (2023) Lecanemab, aducanumab, and gantenerumab\u2014binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease. Neurotherapeutics 20(1):195\u2013206","journal-title":"Neurotherapeutics"},{"issue":"3","key":"5189_CR95","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3233\/JAD-200134","volume":"76","author":"H Guthrie","year":"2020","unstructured":"Guthrie H et al (2020) Safety, tolerability, and pharmacokinetics of crenezumab in patients with mild-to-moderate Alzheimer\u2019s disease treated with escalating doses for up to 133 weeks. J Alzheimers Dis 76(3):967\u2013979","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"5189_CR96","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1002\/alz.13031","volume":"19","author":"KC Holdridge","year":"2023","unstructured":"Holdridge KC et al (2023) Targeting amyloid \u03b2 in Alzheimer\u2019s disease: meta-analysis of low-dose solanezumab in Alzheimer\u2019s disease with mild dementia studies. Alzheimers Dement 19(10):4619\u20134628","journal-title":"Alzheimers Dement"},{"issue":"18","key":"5189_CR97","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA et al (2021) Donanemab in early Alzheimer\u2019s disease. N Engl J Med 384(18):1691\u20131704","journal-title":"N Engl J Med"},{"issue":"20","key":"5189_CR98","doi-asserted-by":"crossref","first-page":"15262","DOI":"10.1021\/acs.jmedchem.1c01300","volume":"64","author":"R Machauer","year":"2021","unstructured":"Machauer R et al (2021) Discovery of umibecestat (CNP520): a potent, selective, and efficacious \u03b2-secretase (BACE1) inhibitor for the prevention of Alzheimer\u2019s disease. J Med Chem 64(20):15262\u201315279","journal-title":"J Med Chem"},{"issue":"24","key":"5189_CR99","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.3390\/molecules27248823","volume":"27","author":"FH Bazzari","year":"2022","unstructured":"Bazzari FH, Bazzari AH (2022) Bace1 inhibitors for Alzheimer\u2019s disease: the past, present and any future? Molecules 27(24):8823","journal-title":"Molecules"},{"key":"5189_CR100","volume":"231","author":"S Li","year":"2022","unstructured":"Li S et al (2022) Novel insights into RIPK1 as a promising target for future Alzheimer\u2019s disease treatment. Pharmacol Ther 231:107979","journal-title":"Pharmacol Ther"},{"issue":"7","key":"5189_CR101","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115374","volume":"28","author":"Z Yang","year":"2020","unstructured":"Yang Z et al (2020) Design, synthesis and evaluation of flurbiprofen-clioquinol hybrids as multitarget-directed ligands against Alzheimer\u2019s disease. Bioorg Med Chem 28(7):115374","journal-title":"Bioorg Med Chem"},{"issue":"11","key":"5189_CR102","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2174\/1567205017666201127163018","volume":"17","author":"A Villarejo-Galende","year":"2020","unstructured":"Villarejo-Galende A et al (2020) Non-steroidal anti-inflammatory drugs as candidates for the prevention or treatment of Alzheimer\u2019s disease: do they still have a role? Curr Alzheimer Res 17(11):1013\u20131022","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"5189_CR103","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/08923973.2021.1981374","volume":"43","author":"A Karkhah","year":"2021","unstructured":"Karkhah A et al (2021) Indomethacin attenuates neuroinflammation and memory impairment in an STZ-induced model of Alzheimer\u2019s like disease. Immunopharmacol Immunotoxicol 43(6):758\u2013766","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"4","key":"5189_CR104","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/joim.13170","volume":"289","author":"I Kalar","year":"2021","unstructured":"Kalar I et al (2021) Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study. J Intern Med 289(4):508\u2013522","journal-title":"J Intern Med"},{"issue":"31","key":"5189_CR105","volume":"101","author":"Q Yang","year":"2022","unstructured":"Yang Q et al (2022) A systematic review of the efficacy of donepezil hydrochloride combined with nimodipine on treating vascular dementia. Medicine 101(31):e29307","journal-title":"Medicine"},{"issue":"6","key":"5189_CR106","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamaneurol.2022.0983","volume":"79","author":"MS Rafii","year":"2022","unstructured":"Rafii MS et al (2022) Safety, tolerability, and immunogenicity of the ACI-24 vaccine in adults with Down syndrome: a phase 1b randomized clinical trial. JAMA Neurol 79(6):565\u2013574","journal-title":"JAMA Neurol"},{"key":"5189_CR107","doi-asserted-by":"crossref","DOI":"10.1002\/alz.065688","volume":"18","author":"E Fiorini","year":"2022","unstructured":"Fiorini E et al (2022) Optimized ACI-24, an amyloid beta (Abeta) vaccine that safely drives immunity to oligomers and Pyroglutamate Abeta, key pathological species of Alzheimer\u2019s disease (AD). Alzheimers Dement 18:e065688","journal-title":"Alzheimers Dement"},{"issue":"12","key":"5189_CR108","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/biology9120425","volume":"9","author":"F Mantile","year":"2020","unstructured":"Mantile F, Prisco A (2020) Vaccination against \u03b2-amyloid as a strategy for the prevention of Alzheimer\u2019s disease. Biology 9(12):425","journal-title":"Biology"},{"key":"5189_CR109","doi-asserted-by":"crossref","DOI":"10.1002\/alz.045720","volume":"16","author":"EP Molina","year":"2020","unstructured":"Molina EP et al (2020) Safety, tolerability and immunogenicity of an active anti-A\u03b240 vaccine (ABvac40) in patients with amnestic mild cognitive impairment (A-MCI) or very mild alzheimer\u2019s disease (VM-AD): a randomized, double-blind, placebo-controlled, phase II trial: human\/human trials: anti-amyloid. Alzheimers Dement 16:e045720","journal-title":"Alzheimers Dement"},{"key":"5189_CR110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fnins.2017.00229","volume":"11","author":"K Yuyama","year":"2017","unstructured":"Yuyama K, Igarashi Y (2017) Exosomes as carriers of Alzheimer\u2019s amyloid-ss. Front Neurosci 11:229","journal-title":"Front Neurosci"},{"issue":"1","key":"5189_CR111","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/10717544.2020.1762262","volume":"27","author":"Y Qi","year":"2020","unstructured":"Qi Y et al (2020) Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles. Drug Delivery 27(1):745\u2013755","journal-title":"Drug Delivery"},{"key":"5189_CR112","doi-asserted-by":"crossref","unstructured":"Abdi SMY, Al-Bakri  SSM and Nordin N (2024)\u00a0Insights on the characteristics and therapeutic potential of mesenchymal stem cell-derived exosomes for mitigation of Alzheimer\u2019s disease\u2019s pathogenicity: a systematic review.\u00a0Cell Biochem Biophys 1\u201316","DOI":"10.1007\/s12013-024-01598-x"},{"issue":"17","key":"5189_CR113","doi-asserted-by":"crossref","first-page":"8129","DOI":"10.7150\/thno.62069","volume":"11","author":"AS Cone","year":"2021","unstructured":"Cone AS et al (2021) Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer\u2019s disease-like phenotypes in a preclinical mouse model. Theranostics 11(17):8129","journal-title":"Theranostics"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05189-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:08:18Z","timestamp":1761908898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05189-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":113,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5189"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05189-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}